You searched for AdHD - Labiotech.eu

News and Trends 2 Dec 2022

Tris Pharma and Pediatrix Therapeutics extend partnership for ADHD portfolio

…ADHD pipeline products in China. Tris says it has a robust portfolio of FDA-approached products for the treatment of attention deficit/hyperactivity disorder (ADHD) and a pipeline of treatments for pain,…

December 2, 2022 - 2 minutesmins - By Liza Laws

News and Trends 30 Aug 2016

New non-amphetaminic ADHD drug ‘speeds’ into Phase II

ADHD is believed to affect up to 7% of people worldwide, but some common therapies bear a shocking resemblance to Speed. A new drug from NLS, Mazindol, just entered Phase…

August 30, 2016 - 2 minutesmins - By Evelyn Warner

Best in Biotech 16 Apr 2024

Seven biotech companies climbing their way up in Colorado

…260 patients with vEDS caused by a COL3A1 mutation. The Colorado-based biotech company also has a portfolio of attention deficit hyperactivity disorder (ADHD) drugs and therapies for allergies in children….

April 16, 2024 - 8 minutesmins - By Roohi Mariam Peter

Best in Biotech 25 Jan 2024

Eight mental health biotech companies trying to make a difference to people’s lives

…mental health company’s psychiatry pipeline includes investigational therapies for the treatment of generalized anxiety disorder, ADHD, and autism spectrum disorder. In December 2023, MindMed announced positive topline results from its…

January 25, 2024 - 11 minutesmins - By Willow Shah-Neville

Best in Biotech 22 Jun 2022

The top psychedelic drug developers leading the market

…anxiety disorder and attention deficit hyperactivity disorder (ADHD). Like psilocybin and DMT, LSD is believed to rewire the brain and provide long-lasting mental health benefits to patients. According to recent…

June 22, 2022 - 7 minutesmins - By Jonathan Smith

News and Trends 30 Nov 2015

Heptares’ G-Protein StaR Platform has now Hooked Pfizer in a Billion Euro Deal

…(a superfamily of 375 receptors), to include Schizophrenia, Alzheimer’s, ADHD and Migraine. Heptares StaR (stabilised receptor) technology forms the backbone of its integrated platform for targeting GPCRs. A StaR protein…

November 30, 2015 - 2 minutesmins - By Dani Bancroft

News and Trends 26 Nov 2015

The UK-Israeli €378M Small-Molecule Offensive Against Migraines

…with a broad neurological drug portfolio to include other indications like Alzheimer’s, Schizophrenia and ADHD. Founded by Fiona Marshall (one of our Top 10 UK Women in Biotech), she now…

November 26, 2015 - 2 minutesmins - By Dani Bancroft

News and Trends 14 Jun 2018

Our Eyes Could Open A Window to Diagnosing Alzheimer’s and Parkinson’s Disease

…the early detection of neurodegenerative diseases easier. The research team and Aura plan to develop the device to be used in other conditions, such as ADHD, autistic spectrum disorders and…

June 14, 2018 - 2 minutesmins - By Alexander Burik

Expert Advice 2 Feb 2024

5 biotech career paths where demand is skyrocketing

…in scarce supply like certain ADHD treatments, GLP-1s, and cell-based therapies,” said Penrose. “Such biotechnology roles offer a degree of job security and a rapid learning curve, with career progression…

February 2, 2024 - 6 minutesmins - By Willow Shah-Neville

News and Trends 20 Nov 2015

Get to Know the Top 50 Women in the UK’s Biotech Scene

…As Founder, Fiona is also the CSO of the Japanese Biopharma Sosei, which acquired Heptares this year in a €373M deal for their pipeline of neurological drugs for Alzheimer’s, ADHD,…

November 20, 2015 - 5 minutesmins - By Dani Bancroft

News and Trends 3 Nov 2022

Trial and new drug for Tourette Syndrome after $250M after funding round completed

…number of patients with Tourette Syndrome have co-morbidities like ADHD or OCD. During the phase 2b study they were allowed to continue their medications for those conditions, and their Tourette symptoms measurably…

November 3, 2022 - 3 minutesmins - By Liza Laws

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: AdHD

Tris Pharma and Pediatrix Therapeutics extend partnership for ADHD portfolio

New non-amphetaminic ADHD drug ‘speeds’ into Phase II

Seven biotech companies climbing their way up in Colorado

Eight mental health biotech companies trying to make a difference to people’s lives

The top psychedelic drug developers leading the market

Heptares’ G-Protein StaR Platform has now Hooked Pfizer in a Billion Euro Deal

The UK-Israeli €378M Small-Molecule Offensive Against Migraines

Our Eyes Could Open A Window to Diagnosing Alzheimer’s and Parkinson’s Disease

5 biotech career paths where demand is skyrocketing

Get to Know the Top 50 Women in the UK’s Biotech Scene

Trial and new drug for Tourette Syndrome after $250M after funding round completed

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!